Implant Interface Articles & Analysis
14 news found
Synchron, an endovascular brain-computer interface (BCI) company, today announced the first human BCI implant in the United States. ...
Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer. ...
The second-generation programmer has a modernized design, operates on an upgraded cellular network that enables remote view access, and includes an improved user interface that simplifies implantable pulse generator (IPG) programming. The new Barostim Programmer is compatible with all Barostim implantable systems. "The new Barostim Programmer ...
ByCVRx
“Our recent results presented at the American Academy of Neurology Conference 2022 show that our permanent BCI implant is safe, and can improve independence and quality of life for those living with ...
Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. Paralysis is a devastating condition for more than 5 million patients in the United States Synchron, an endovascular brain-computer (BCI) interface company, today announced the enrollment of the first patient in the US ...
Four Patients With ALS Who Received Stentrode™ Implant Gained Ability to Perform Daily Online Tasks No Serious Adverse Events Reported after 12 Months Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s ...
Collaborative robot to execute the preplanned gesture The objective of the CoBot eCential Robotics is to enable the surgeon to perform the procedure as planned with efficiency and reproducible precision. The practitioner plans the implants intraoperatively in relation to the image of the patient in the intervention position, thanks to automatic pre-positioning, and adjusts the ...
Synchron, a brain computer interface (BCI) company, today announced the expansion of its advisory board comprised of industry pioneers, to provide strategic guidance in support of the Company’s clinical development plans, corporate strategy and growth. ...
Synchron, a brain computer interface company, today announced a Twitter takeover by Philip O’Keefe, one of the patients implanted with the Stentrode brain computer interface. ...
Patients begin using the device at home soon after implantation and may wirelessly control external devices by thinking about moving their limbs. ...
Additive Implants, Inc. is pleased to announce it received regulatory clearance to market in the US its second product, the SureMAX®-X Cervical Spacer. This 3D printed titanium spacer has a unique patented* design to create uniform end plate coverage and optimize load distribution. “Maximizing implant coverage of the endplates and providing for more ...
Additive Implants, Inc. is pleased to announce it received regulatory clearance to market in the US its second product, the SureMAX®-X Cervical Spacer. This 3D printed titanium spacer has a unique patented* design to create uniform end plate coverage and optimize load distribution. “Maximizing implant coverage of the endplates and providing for more ...
With over 5,000 FortiCore interbodies now implanted, Nanovis plans to further accelerate its technology driven growth with the expansion of their FortiCore PLIF product line with the addition of 22 mm and 25 mm lengths that can be rotated in situ for optimal placement. ...
ByNanovis
– Sept. 11, 2018 – Nanovis, a leader in nanomedicine for the spine, today announced a licensing agreement with the University of Nevada, Reno for a key nanosurface technology patent covering the use of ceramics on implants with nanopores. This foundational patent allows development of ceramics for medical implants with nanosurfacing that enhances cell ...
ByNanovis